DENTSPLY SIRONA Inc
NASDAQ:XRAY
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
17.26
37.39
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one XRAY stock under the Base Case scenario is 41.46 USD. Compared to the current market price of 18.77 USD, DENTSPLY SIRONA Inc is Undervalued by 55%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
DENTSPLY SIRONA Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for XRAY cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
DENTSPLY SIRONA Inc
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
DENTSPLY SIRONA Inc
Balance Sheet Decomposition
DENTSPLY SIRONA Inc
Current Assets | 1.9B |
Cash & Short-Term Investments | 296m |
Receivables | 671m |
Other Current Assets | 954m |
Non-Current Assets | 4.7B |
PP&E | 967m |
Intangibles | 3.5B |
Other Non-Current Assets | 263m |
Current Liabilities | 1.5B |
Accounts Payable | 297m |
Accrued Liabilities | 675m |
Other Current Liabilities | 570m |
Non-Current Liabilities | 2.6B |
Long-Term Debt | 1.8B |
Other Non-Current Liabilities | 798m |
Earnings Waterfall
DENTSPLY SIRONA Inc
Revenue
|
3.9B
USD
|
Cost of Revenue
|
-1.9B
USD
|
Gross Profit
|
2B
USD
|
Operating Expenses
|
-1.8B
USD
|
Operating Income
|
263m
USD
|
Other Expenses
|
-676m
USD
|
Net Income
|
-413m
USD
|
Free Cash Flow Analysis
DENTSPLY SIRONA Inc
USD | |
Free Cash Flow | USD |
Dentsply Sirona reported Q3 revenue of $951 million, up 1.3% organically due to distributor order timing. However, excluding this impact, organic sales fell by 0.8%. The Orthodontics and Implants segment underperformed, with a notable decline of 3.9% in organic sales. A voluntary suspension of the Byte Aligners business has affected approximately $40 million in revenue and prompted a strategic review. For 2024, the company revised its guidance, forecasting organic sales down 2.5% to 3.5%, with net sales anticipated between $3.79 billion and $3.82 billion. Adjusted EBITDA margin expectations decreased to around 17.5%, down from greater than 18% previously.
What is Earnings Call?
XRAY Profitability Score
Profitability Due Diligence
DENTSPLY SIRONA Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.
Score
DENTSPLY SIRONA Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.
XRAY Solvency Score
Solvency Due Diligence
DENTSPLY SIRONA Inc's solvency score is 45/100. The higher the solvency score, the more solvent the company is.
Score
DENTSPLY SIRONA Inc's solvency score is 45/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
XRAY Price Targets Summary
DENTSPLY SIRONA Inc
According to Wall Street analysts, the average 1-year price target for XRAY is 24.91 USD with a low forecast of 19.19 USD and a high forecast of 36.75 USD.
Dividends
Current shareholder yield for XRAY is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
XRAY Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Dentsply Sirona, Inc. engages in the design, manufacture, sales and distribution of professional dental products and technologies. The company is headquartered in York, Pennsylvania and currently employs 15,000 full-time employees. The firm develops, manufactures and markets solutions, including dental equipment and dental consumable products. The Company’s segments include Technologies & Equipment (T&E) and Consumables. The T&E segment is engaged in designing, manufacturing, sales and distribution of its Dental Technology and Equipment Products and Healthcare Consumable Products. Its products include dental implants, computer-aided design/computer-aided manufacturing systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as consumable medical device products. The Consumables segment is engaged in designing, manufacturing, sales and distribution of the Company's Dental Consumable Products, which include preventive, restorative, endodontic and dental laboratory products. The company also offers treatment planning and a clear aligner solution delivered directly to a consumer's home.
Contact
IPO
Employees
Officers
The intrinsic value of one XRAY stock under the Base Case scenario is 41.46 USD.
Compared to the current market price of 18.77 USD, DENTSPLY SIRONA Inc is Undervalued by 55%.